rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
7
|
pubmed:dateCreated |
2009-7-10
|
pubmed:abstractText |
Although tissue microarray (TMA) studies of histopathologic material have been frequently reported in studies of malignant diseases, the question of sample size (i.e., the diameter and the number of tissue cylinders investigated) has been rarely discussed. This study addresses the methodologic question of sample size in a variety of tumor types.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1538-7755
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
18
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2014-21
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:19531681-Adenocarcinoma,
pubmed-meshheading:19531681-Breast Neoplasms,
pubmed-meshheading:19531681-Carcinoma,
pubmed-meshheading:19531681-Endometrial Neoplasms,
pubmed-meshheading:19531681-Female,
pubmed-meshheading:19531681-Humans,
pubmed-meshheading:19531681-Immunohistochemistry,
pubmed-meshheading:19531681-Ki-67 Antigen,
pubmed-meshheading:19531681-Lung Neoplasms,
pubmed-meshheading:19531681-Male,
pubmed-meshheading:19531681-Receptor, erbB-2,
pubmed-meshheading:19531681-Receptors, Estrogen,
pubmed-meshheading:19531681-Reproducibility of Results,
pubmed-meshheading:19531681-Sample Size,
pubmed-meshheading:19531681-Tissue Array Analysis,
pubmed-meshheading:19531681-Tumor Markers, Biological,
pubmed-meshheading:19531681-Tumor Suppressor Protein p53
|
pubmed:year |
2009
|
pubmed:articleTitle |
Tissue microarray validation: a methodologic study with special reference to lung cancer.
|
pubmed:affiliation |
School of Health and Medical Sciences, Orebro University, Orebro, Sweden. christina.karlsson@oru.se
|
pubmed:publicationType |
Journal Article,
Validation Studies
|